Tag Archives: Avastin
Bevacizumab Beneficial in Newly Diagnosed Glioblastoma?
A large study of patients with newly diagnosed glioblastoma multiforme suggests that the addition of bevacizumab (Avastin) and irinotecan (Camptosar) to standard chemoradiation can extend survival (progression and overall survival) by 6 months. Bevacizumab (Avastin) is an inhibitor of vascular … Continue reading
Efficacy and tolerability of Avastin plus Xeloda as first-line therapy in patients with advanced Liver Cancer
Liver cancer is the fifth most common cancer worldwide and the third most common cause of cancer mortality. More than 80% of cases occur in East Asia and sub-Sharan Africa, and the incidence is increasing in Europe and the US. … Continue reading
Avastin Boosts Progression-Free Survival in Ovarian Cancer Patients
Adding bevacizumab (Avastin) to chemotherapy, followed by bevacizumab as maintenance therapy, can significantly prolong progression-free survival in women with advanced ovarian cancer. The study consisted of 1873 women with newly diagnosed stage III (macroscopic residual disease) or stage IV ovarian, primary peritoneal, … Continue reading
Pancreatic cancer – Causes, Prevention, Prognosis, Diagnosis and Latest Treatment
Prevalence Pancreatic cancer is the fourth most common cause of adult cancer death, accounting for an estimated 42,470 new cases and 35,240 deaths in USA for 2009. The high mortality rate is due to the high incidence of metastatic disease … Continue reading